Literature DB >> 23002278

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

J L Lopez Guerra1, D R Gomez, S H Lin, L B Levy, Y Zhuang, R Komaki, J Jaen, A A Vaporciyan, S G Swisher, J D Cox, Z Liao, D C Rice.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the actuarial risk of local and regional failure in patients with completely resected non-small-cell lung cancer (NSCLC), and to assess surgical and pathological factors affecting this risk. PATIENTS AND METHODS: Between January 1998 and December 2009, 1402 consecutive stage I-III (N0-N1) NSCLC patients underwent complete resection without adjuvant radiation therapy. The median follow-up was 42 months.
RESULTS: Local-regional recurrence was identified in 9% of patients, with local failure alone in 3% of patients, regional failure alone in 4% of patients, and both local and regional failure simultaneously in 2% of patients. Patients who had local failure were found to be at increased risk of mortality. By multivariate analyses, three variables were shown to be independently significant risk factors for local [surgical procedure (single/multiple wedges+segmentectomy versus lobectomy+bilobectomy+pneumonectomy), tumor size>2.7 cm, and visceral pleural invasion] and regional (pathologic N1 stage, visceral pleural invasion, and lymphovascular space invasion, LVI) recurrence, respectively.
CONCLUSION: Patients with N0-N1 disease have low rates of locoregional recurrence after surgical resection. However, several prognostic factors can be identified that increase this risk and identify patients who may benefit from adjuvant treatment.

Entities:  

Mesh:

Year:  2012        PMID: 23002278      PMCID: PMC3525136          DOI: 10.1093/annonc/mds274

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  28 in total

1.  Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  L Crinò; W Weder; J van Meerbeeck; E Felip
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases.

Authors:  E van Velzen; R J Snijder; A Brutel de la Rivière; H J Elbers; J M van den Bosch
Journal:  Chest       Date:  1996-12       Impact factor: 9.410

3.  Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up.

Authors:  Ryo Maeda; Junji Yoshida; Tomoyuki Hishida; Keiju Aokage; Mitsuyo Nishimura; Yutaka Nishiwaki; Kanji Nagai
Journal:  Chest       Date:  2010-04-09       Impact factor: 9.410

4.  Prognostic impact of histology on early-stage non-small cell lung cancer.

Authors:  Ryo Maeda; Junji Yoshida; Genichiro Ishii; Tomoyuki Hishida; Mitsuyo Nishimura; Kanji Nagai
Journal:  Chest       Date:  2010-12-16       Impact factor: 9.410

5.  Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.

Authors:  Hyeon-Kyoung Koo; Sang-Man Jin; Chang-Hoon Lee; Hyo-Jeong Lim; Jae-Joon Yim; Young Tae Kim; Seok-Chul Yang; Chul-Gyu Yoo; Sung Koo Han; Joo Hyun Kim; Young-Soo Shim; Young Whan Kim
Journal:  Lung Cancer       Date:  2010-12-18       Impact factor: 5.705

6.  Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer.

Authors:  John M Varlotto; Abram Recht; John C Flickinger; Laura N Medford-Davis; Anne-Marie Dyer; Malcolm M DeCamp
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

7.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

8.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

9.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

10.  Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.

Authors:  Chris R Kelsey; Lawrence B Marks; Donna Hollis; Jessica L Hubbs; Neal E Ready; Thomas A D'Amico; Jessamy A Boyd
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

View more
  22 in total

1.  Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.

Authors:  Sameer A Hirji; Thomas A D'Amico
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.

Authors:  Bing-Yen Wang; Jing-Yang Huang; Heng-Chung Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Wei-Heng Hung; Ya-Fu Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-08       Impact factor: 4.553

3.  Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.

Authors:  Ugur Selek; Joe Y Chang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy.

Authors:  Christoph Pöttgen; Jehad Abu Jawad; Eleni Gkika; Lutz Freitag; Wolfgang Lübcke; Stefan Welter; Thomas Gauler; Martin Schuler; Wilfried Ernst Erich Eberhardt; Georgios Stamatis; Martin Stuschke
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  Visceral Pleural Invasion in Pulmonary Adenocarcinoma: Differences in CT Patterns between Solid and Subsolid Cancers.

Authors:  Benedikt H Heidinger; Ursula Schwarz-Nemec; Kevin R Anderson; Constance de Margerie-Mellon; Antonio C Monteiro Filho; Yigu Chen; Marius E Mayerhoefer; Paul A VanderLaan; Alexander A Bankier
Journal:  Radiol Cardiothorac Imaging       Date:  2019-08-29

6.  Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Authors:  Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah
Journal:  Ann Thorac Surg       Date:  2018-07-19       Impact factor: 4.330

Review 7.  Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).

Authors:  A Gómez; J A González; F Couñago; C Vallejo; F Casas; N Rodríguez de Dios
Journal:  Clin Transl Oncol       Date:  2015-08-18       Impact factor: 3.405

Review 8.  How and when to use genetic markers for nonsmall cell lung cancer.

Authors:  Donald R Lazarus; David E Ost
Journal:  Curr Opin Pulm Med       Date:  2013-07       Impact factor: 3.155

9.  Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.

Authors:  Olga V Pankova; Evgeny V Denisov; Anastasia A Ponomaryova; Tatiana S Gerashchenko; Sergey A Tuzikov; Vladimir M Perelmuter
Journal:  Tumour Biol       Date:  2015-10-11

10.  Questionnaire survey comparing surgery and stereotactic body radiotherapy for lung cancer: lessons from patients with experience of both modalities.

Authors:  Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Masataka Taguri; Nobuyuki Horita; Yu Hara; Takahisa Eriguchi; Takeshi Akiba; Akitomo Sugawara; Etsuo Kunieda; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.